Stocks and Investing
Stocks and Investing
Wed, July 5, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Oren Livnat Reiterated (AVDL) at Strong Buy with Increased Target to $21 on, Jul 5th, 2023
Oren Livnat of HC Wainwright & Co., Reiterated "Avadel Pharmaceuticals plc" (AVDL) at Strong Buy with Increased Target from $18 to $21 on, Jul 5th, 2023.
Oren has made no other calls on AVDL in the last 4 months.
There are 4 other peers that have a rating on AVDL. Out of the 4 peers that are also analyzing AVDL, 0 agree with Oren's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Oren
- Ami Fadia of "Needham" Reiterated at Strong Buy and Held Target at $18 on, Friday, June 30th, 2023
- Francois Brisebois of "Oppenheimer" Maintained at Buy with Increased Target to $25 on, Friday, June 30th, 2023
- Matthew Kaplan of "Ladenburg Thalmann" Maintained at Strong Buy with Increased Target to $16 on, Tuesday, May 2nd, 2023
- Patrick Dolezal of "LifeSci Capital" Maintained at Buy with Increased Target to $26 on, Tuesday, May 2nd, 2023
Contributing Sources